Skip to content

Saima M. Ali

NPI 1932185733ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Orlando, FL

Internal Medicine, Endocrinology, Diabetes & Metabolism in Orlando, Florida, licensed in FL, with an NPI issued in December 2005. Enrolled in Medicare as practitioner - endocrinology. Novo Nordisk Inc was the largest of 5 companies reporting payments in 2025, $177.93 in all, mostly food and beverage.

Overview

NPI1932185733
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedDec 22, 2005
Last updated in NPPESFeb 20, 2024
Certified by providerFeb 20, 2024

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (FL)

Medicare sources and data years

Education and affiliations

Graduation year1993
Medicare specialtyEndocrinology

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$177.93 · 9 payments from 5 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$177.93 · 9 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Orlando

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Florida →